Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job

Workshop

[In-Person] Project/Program Management Elevating Drug Development


Speakers: Shoba Gopalan, Synthekine; Cynthia (Cindy) Shafer, Arcus Biosciences; Han Zhang, Synthekine; Chris Warner, Synthekine; Feng Gu, Novartis; Debjani Dutta, Gilead
Organizers: Shoba Gopalan, PhD (Synthekine)
Date: 2024-03-07
Time: 8:45-17:00 Pacific Time
Registration fee: Regular attendees: $295; Academic/Students/Postdocs: $45; Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $695, Happy Hour Sponsorship: $975; Lunch Sponsorship: $1250; On-site Registration: $500
Location: Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor:
Vendor show vendors registered to date: (1)Meadowhawk Biolabs
Registration: http://www.PBSS.org
Registration deadline:2024-03-06  (it will close sooner if the seating cap is reached)

About the Topic

1Evolving Role of a Project/Program Manager - A comprehensive overview of a project or program management role from development through commercialization. This presentation encompasses the challenges of managing scope, cost, and timelines in drug development within a resource-constrained setting, highlighting tradeoffs. Additionally, it explores communication strategies throughout the program lifecycle and distinguishes between overarching strategies and tactical approaches- Shoba Gopalan.

2. Chief of Staff as a Strategic Partner in Clinical Development- Career growth opportunities for program managers - Cindy Shafer.

3. Portfolio, program, and project team structure to support drug development-Discuss structures to support high performing, efficient, nimble, and productive teams in Biotech – Han Zhang, Chris Warner.

4. Overview of Global Health Project Management at Novartis BioMedical Research- Discuss structures to support high performing, efficient, nimble, and productive teams in Pharma - Feng Gu.

5. Traits of a Successful Program Manager- Han Zhang-A proficient project manager wears many hats, excelling as a mindful leader, engaging entertainer, effective communicator, skilled negotiator, knowledgeable expert, adept plate-spinner, emotionally intelligent leader, and programmatically proactive executor.

6. Navigating Governance & stakeholder management in Pharma-Debjani Dutta.

7. Case study Cell therapy program – Chris Warner, Han Zhang, Shoba Gopalan.


About the Speakers

Time (PST) 

Topic

Presenter

8:45-9:00 am 

PBSS Welcome and Introduction 

Shichang Miao, PhD, PBSS 

9:00-9:30 am 

Evolving Role of a Project/Program Manager

Shoba Gopalan, PhD, Vice President, Program and Alliance Management, Synthekine

9:30-10:15 am

Chief of Staff as a Strategic Partner in Clinical Development

Cynthia (Cindy) Shafer, PhD, Chief of Staff, Arcus Biosciences

10:15-10:35 am

Break

-

10:35-11:20 am

Portfolio, Program, and Project Team Structure to Support Drug Development

Han Zhang, PhD, Director, Program management, Synthekine; Chris Warner, PhD, Director, Program Management, Synthekine

11:20 am-12:05 pm

Overview of Global Health Project Management at Novartis BioMedical Research

Feng Gu, PhD, Executive Director, Portfolio and Global Program Management, Biomedical Research at Novartis Global Health

12:05-1:10 pm

Lunch 

-

 

1:10-1:40 pm

Traits of a Successful Program Manager

Han Zhang, PhD, Director, Program management, Synthekine

1:40-2:00 pm

Break

2:00-2:45 pm

Navigating Governance & Stakeholder Management in Pharma

Debjani Dutta, Executive Director, Project Management, Oncology, Gilead Sciences

2:45-3.30 pm

Case study Cell therapy program

Chris Warner, PhD, Director, Program Management, Synthekine; Han Zhang, PhD, Director, Program management, Synthekine; Shoba Gopalan, PhD, Vice President, Program and Alliance Management, Synthekine

3:30-4:00 pm

Panel Discussion

All speakers

4:00-5:00 pm

Happy Hour

-


2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
┬ęPharmaceutical & BioScience Society, International; Last Modified: 4/23/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Submit a Text Ad